Related Experiment Video
Updated: Mar 27, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Association between hepatitis B and metabolic syndrome: Current state of the art
Peter Jarcuska1, Sylvia Drazilova1, Jan Fedacko1
1Peter Jarcuska, Jan Fedacko, Daniel Pella, Martin Janicko, 1 Department of Internal Medicine, University Hospital and Pavol Jozef Šafárik University in Kosice, 04001 Košice, Slovakia.
Insights
Metabolic syndrome (MetS) worsens outcomes for chronic hepatitis B (CHB) patients, increasing risks of liver cirrhosis and cancer. Lifestyle and medical interventions are crucial for managing these risks.
Area of Science:
- Hepatology
- Metabolic Diseases
- Public Health
Background:
- Chronic hepatitis B (CHB) is a significant global health concern, elevating the risk of liver cirrhosis and hepatocellular carcinoma.
- Metabolic syndrome (MetS) is prevalent in developed nations, linked to cardiovascular disease, diabetes, and cancer.
Purpose of the Study:
- To systematically review existing literature on the relationship between Metabolic Syndrome and Chronic Hepatitis B infection.
- To investigate the impact of MetS on the progression of liver disease in CHB patients.
Main Methods:
- Systematic literature review of published studies.
- Analysis of correlations between CHB, MetS, and related conditions like non-alcoholic fatty liver disease and dyslipidemia.
Main Results:
- Variable correlations observed between CHB and MetS, non-alcoholic fatty liver disease, and dyslipidemia.
- No current evidence links CHB with diabetes mellitus or atherosclerosis.
- MetS presence in CHB patients elevates the risk of fibrosis, cirrhosis, and hepatocellular carcinoma.
Conclusions:
- Metabolic syndrome exacerbates liver disease progression and cancer risk in Chronic Hepatitis B patients.
- Lifestyle modifications and pharmacological treatments are essential to mitigate complications associated with CHB and MetS.
Abstract:
Chronic hepatitis B (CHB) is a global health issue that increases the risk of liver cirrhosis and hepatocellular carcinoma in infected patients. Metabolic syndrome (MetS) is a disease endemic mostly to the developed countries. It is associated with high cardiovascular mortality and morbidity, diabetes mellitus as well as cancer. In this manuscript, we systematically review the published data on the relationship between MetS and CHB infection. Multiple studies have described highly variable correlations between CHB on one hand and MetS, non-alcoholic fatty liver disease and dyslipidemia on the other. No association between CHB and diabetes mellitus or atherosclerosis has been described as of now. The presence of MetS in patients infected with hepatitis B virus increases the risk of fibrosis, cirrhosis and hepatocellular carcinoma. Appropriate lifestyle, but also pharmacological interventions are needed to prevent the development of these complications.
More Related Videos
Related Concept Videos
Hepatitis
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Obesity

